Dexco (DXCO3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
6 Jul, 2026Executive summary
Pro forma adjusted and recurring EBITDA reached R$1,313 million in 1H25, driven by strong Wood Division and LD Celulose performance, with LD Celulose operating at full capacity and delivering robust margins.
Consolidated net revenue for 2Q25 rose 6.3% year-over-year to R$2,121.7 million, led by Wood Division and forestry trading, partially offsetting declines in Finishes and Tiles.
Adjusted & Recurring EBITDA for 2Q25 was R$442.7 million, up 17.6% year-over-year, with a margin of 20.9%.
Recurring net income for 2Q25 was R$29.9 million, down 71.5% year-over-year, mainly due to a high base in 2Q24 and negative financial results.
Sustaining free cash flow was negative R$90.6 million, reflecting higher working capital needs and inventory replenishment.
Financial highlights
Excluding LD Celulose, adjusted and recurring EBITDA was R$443 million in 2Q25 (margin 20.9%) and R$788 million in 1H25 (margin 19.6%).
Wood Division adjusted and recurring EBITDA was R$427.9 million in 2Q25, up 34.3% year-over-year, with a margin of 29.9%.
LD Celulose 2Q25 EBITDA reached R$529.1 million (margin 60.5%), with Dexco's share of net income at R$259.5 million.
Net debt at quarter-end was R$5,499.3 million, up 5.3% year-over-year; leverage at 3.39x net debt/EBITDA.
Sustaining CAPEX for 2Q25 was R$205.5 million, down 22.7% year-over-year; total CAPEX for 1H25 was R$366.9 million.
Outlook and guidance
Operational discipline and efficiency gains are expected to support improved profitability in 2H25, with a positive outlook for Wood and Tiles Divisions.
Botucatu plant ramp-up and manufacturing optimization to drive efficiency in Tiles Division.
Metals & Sanitary Ware Division anticipates operational improvements and cost control from factory reorganization.
LD Celulose faces a scheduled maintenance shutdown in H2 2025, but outlook remains positive.
Dividends from LD Celulose expected to begin in 2026, with potential for earlier distribution as de-leveraging progresses.
Latest events from Dexco
- Proforma EBITDA up 10.2% to R$611.2M, but consolidated EBITDA and revenue declined.DXCO3
Q1 20258 Jul 2026 - Wood and LD Celulose strength offset Tiles and Metals weakness amid high leverage and restructuring.DXCO3
Q4 20258 Jul 2026 - EBITDA up 38.3% and net income up 22.7%, with margin and cash flow gains.DXCO3
Q1 20268 Jul 2026 - Recurring EBITDA was R$566.5m, but net income fell on weak Tiles and higher financial costs.DXCO3
Q3 20256 Jul 2026 - Net revenue up 11.5% and EBITDA up 18.4%, but net income down 26.1% on portfolio shifts.DXCO3
Q4 20243 Jul 2026 - Strong 3Q24 revenue and EBITDA growth, portfolio shift, and improved leverage.DXCO3
Q3 20243 Jul 2026 - Adjusted and Recurring EBITDA (pro forma) rose 12.1% year-over-year to R$560.6 million.DXCO3
Q2 20243 Jul 2026